AKR1B10 and non-small cell lung carcinoma: Fukumoto et al. [90] demonstrated overexpression of AKR1B10 in smoking-induced non-small cell lung cancer (NSCLC), Kang et al. [91] reported significantly higher expression of AKR1B10 in tumor samples from NSCLC patients compared to patients with benign lung disease and normal controls.